VBIV Annual Revenue
$8.68 M
+$7.60 M+702.40%
31 December 2023
Summary:
As of January 24, 2025, VBIV annual revenue is $8.68 million, with the most recent change of +$7.60 million (+702.40%) on December 31, 2023. During the last 3 years, it has risen by +$7.62 million (+718.28%).VBIV Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VBIV Quarterly Revenue
$1.21 M
+$361.00 K+42.32%
31 March 2024
Summary:
As of January 24, 2025, VBIV quarterly revenue is $1.21 million, with the most recent change of +$361.00 thousand (+42.32%) on March 31, 2024. Over the past year, it has increased by +$494.00 thousand (+68.61%).VBIV Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VBIV TTM Revenue
$9.41 M
+$729.00 K+8.40%
31 March 2024
Summary:
As of January 24, 2025, VBIV TTM revenue is $9.41 million, with the most recent change of +$729.00 thousand (+8.40%) on March 31, 2024. Over the past year, it has increased by +$7.60 million (+418.51%).VBIV TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VBIV Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +702.4% | +68.6% | +418.5% |
| 3 y3 years | +718.3% | +314.3% | +769.8% |
| 5 y5 years | +158.8% | +314.3% | +769.8% |
VBIV Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | at high | -81.7% | at high |
VBI Vaccines Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | $1.21 M(+42.3%) | $9.41 M(+8.4%) |
| Dec 2023 | $8.68 M(+702.4%) | $853.00 K(-87.1%) | $8.68 M(+6.9%) |
| Sept 2023 | - | $6.62 M(+820.0%) | $8.12 M(+347.5%) |
| June 2023 | - | $720.00 K(+48.5%) | $1.81 M(+26.0%) |
| Mar 2023 | - | $485.00 K(+65.5%) | $1.44 M(+33.2%) |
| Dec 2022 | $1.08 M(+71.5%) | $293.00 K(-7.6%) | $1.08 M(+24.4%) |
| Sept 2022 | - | $317.00 K(-8.4%) | $870.00 K(+31.8%) |
| June 2022 | - | $346.00 K(+174.6%) | $660.00 K(+44.7%) |
| Mar 2022 | - | $126.00 K(+55.6%) | $456.00 K(-27.7%) |
| Dec 2021 | $631.00 K(-40.5%) | $81.00 K(-24.3%) | $631.00 K(-11.6%) |
| Sept 2021 | - | $107.00 K(-24.6%) | $714.00 K(-21.1%) |
| June 2021 | - | $142.00 K(-52.8%) | $905.00 K(-4.4%) |
| Mar 2021 | - | $301.00 K(+83.5%) | $947.00 K(-10.7%) |
| Dec 2020 | $1.06 M(-52.2%) | $164.00 K(-45.0%) | $1.06 M(-27.9%) |
| Sept 2020 | - | $298.00 K(+62.0%) | $1.47 M(-19.2%) |
| June 2020 | - | $184.00 K(-55.7%) | $1.82 M(-20.0%) |
| Mar 2020 | - | $415.00 K(-27.7%) | $2.28 M(+2.5%) |
| Dec 2019 | $2.22 M(-33.8%) | $574.00 K(-11.3%) | $2.22 M(-48.7%) |
| Sept 2019 | - | $647.00 K(+1.1%) | $4.33 M(+9.8%) |
| June 2019 | - | $640.00 K(+77.8%) | $3.94 M(+11.5%) |
| Mar 2019 | - | $360.00 K(-86.6%) | $3.54 M(+5.4%) |
| Dec 2018 | $3.35 M(+287.9%) | $2.68 M(+936.3%) | $3.35 M(+284.7%) |
| Sept 2018 | - | $259.00 K(+10.7%) | $872.00 K(+8.2%) |
| June 2018 | - | $234.00 K(+31.5%) | $806.00 K(-12.0%) |
| Mar 2018 | - | $178.00 K(-11.4%) | $916.00 K(+5.9%) |
| Dec 2017 | $865.00 K | $201.00 K(+4.1%) | $865.00 K(+8.0%) |
| Sept 2017 | - | $193.00 K(-43.9%) | $801.00 K(-9.9%) |
| June 2017 | - | $344.00 K(+170.9%) | $889.00 K(+41.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | $127.00 K(-7.3%) | $627.00 K(+14.4%) |
| Dec 2016 | $548.00 K(-42.6%) | $137.00 K(-51.2%) | $548.00 K(+36.7%) |
| Sept 2016 | - | $281.00 K(+242.7%) | $401.00 K(+79.0%) |
| June 2016 | - | $82.00 K(+70.8%) | $224.00 K(+57.7%) |
| Mar 2016 | - | $48.00 K(-580.0%) | $142.00 K(+51.1%) |
| Dec 2015 | $955.00 K(>+9900.0%) | -$10.00 K(-109.6%) | $94.00 K(-9.6%) |
| Sept 2015 | - | $104.00 K(>+9900.0%) | $104.00 K(>+9900.0%) |
| Mar 2004 | $100.00(-80.0%) | - | - |
| Mar 2003 | $500.00(0.0%) | - | - |
| Mar 2002 | $500.00(>+9900.0%) | - | - |
| Sept 2001 | - | $300.00(>+9900.0%) | $300.00(>+9900.0%) |
| June 2001 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2001 | $0.00(0.0%) | $0.00(0.0%) | $67.50 K(0.0%) |
| Dec 2000 | - | $0.00(0.0%) | $67.50 K(-50.5%) |
| Sept 2000 | - | $0.00(-100.0%) | $136.50 K(-33.3%) |
| June 2000 | - | $67.50 K(>+9900.0%) | $204.60 K(-0.1%) |
| Mar 2000 | $0.00(0.0%) | $0.00(-100.0%) | $204.90 K(+46.5%) |
| Dec 1999 | - | $69.00 K(+1.3%) | $139.90 K(+2.9%) |
| Sept 1999 | - | $68.10 K(+0.4%) | $135.90 K(+2.0%) |
| June 1999 | - | $67.80 K(-204.3%) | $133.30 K(-0.2%) |
| Mar 1999 | $0.00(-100.0%) | -$65.00 K(-200.0%) | $133.60 K(-32.9%) |
| Dec 1998 | - | $65.00 K(-0.8%) | $199.20 K(-2.4%) |
| Sept 1998 | - | $65.50 K(-3.8%) | $204.10 K(-3.3%) |
| June 1998 | - | $68.10 K(>+9900.0%) | $211.00 K(-2.0%) |
| Mar 1998 | $70.40 K(-2.9%) | $600.00(-99.1%) | $215.30 K(+0.3%) |
| Dec 1997 | - | $69.90 K(-3.5%) | $214.70 K(+48.3%) |
| Sept 1997 | - | $72.40 K(0.0%) | $144.80 K(+100.0%) |
| June 1997 | - | $72.40 K | $72.40 K |
| Mar 1997 | $72.50 K | - | - |
FAQ
- What is VBI Vaccines annual revenue?
- What is the all time high annual revenue for VBI Vaccines?
- What is VBI Vaccines annual revenue year-on-year change?
- What is VBI Vaccines quarterly revenue?
- What is the all time high quarterly revenue for VBI Vaccines?
- What is VBI Vaccines quarterly revenue year-on-year change?
- What is VBI Vaccines TTM revenue?
- What is the all time high TTM revenue for VBI Vaccines?
- What is VBI Vaccines TTM revenue year-on-year change?
What is VBI Vaccines annual revenue?
The current annual revenue of VBIV is $8.68 M
What is the all time high annual revenue for VBI Vaccines?
VBI Vaccines all-time high annual revenue is $8.68 M
What is VBI Vaccines annual revenue year-on-year change?
Over the past year, VBIV annual revenue has changed by +$7.60 M (+702.40%)
What is VBI Vaccines quarterly revenue?
The current quarterly revenue of VBIV is $1.21 M
What is the all time high quarterly revenue for VBI Vaccines?
VBI Vaccines all-time high quarterly revenue is $6.62 M
What is VBI Vaccines quarterly revenue year-on-year change?
Over the past year, VBIV quarterly revenue has changed by +$494.00 K (+68.61%)
What is VBI Vaccines TTM revenue?
The current TTM revenue of VBIV is $9.41 M
What is the all time high TTM revenue for VBI Vaccines?
VBI Vaccines all-time high TTM revenue is $9.41 M
What is VBI Vaccines TTM revenue year-on-year change?
Over the past year, VBIV TTM revenue has changed by +$7.60 M (+418.51%)